SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-006161
Filing Date
2015-04-09
Accepted
2015-04-09 07:57:14
Documents
1
Period of Report
2015-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 16467
  Complete submission text file 0001179110-15-006161.txt   17842
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DRIVE OSIRIS THERAPEUTICS, INC. COLUMBIA MD 21046
Business Address
Danilkovitch Alla (Reporting) CIK: 0001636236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32966 | Film No.: 15760359